82 related articles for article (PubMed ID: 5890823)
1. [Treatment of prostatic cancer with local injection of estrogenic hormones].
Kato T; Ishibe T; Fukushige M; Kajio K; Ito Y
Hinyokika Kiyo; 1965 Jul; 11(7):602-4. PubMed ID: 5890823
[No Abstract] [Full Text] [Related]
2. Polyestradiol phosphate and ethinyl estradiol in treatment of prostatic carcinoma.
Lindstedt E
Scand J Urol Nephrol Suppl; 1980; 55():95-7. PubMed ID: 6938044
[TBL] [Abstract][Full Text] [Related]
3. Progynon, a depot preparation with oestrogenic action, in the treatment of prostatic carcinoma.
Birke G; Wadström LB
Acta Chir Scand; 1965 Oct; 130(4):388-92. PubMed ID: 5842513
[No Abstract] [Full Text] [Related]
4. [Thyroid hormones in metastasizing prostate cancer treated with polyestradiol phosphate].
Dunzendorfer U; Schulz H
Z Urol Nephrol; 1982 Jul; 75(7):493-500. PubMed ID: 6183845
[TBL] [Abstract][Full Text] [Related]
5. [Prostatic cancer--treatment with extramustine phosphate(Estracyt). An easier application form].
Erichsen HG; Nygaard E
Tidsskr Nor Laegeforen; 1974 Oct; 94(28):1901-2. PubMed ID: 4424279
[No Abstract] [Full Text] [Related]
6. [Treatment of advanced prostatic carcinoma using polyestradiol phosphate (Estradurin)].
Bülow H
Med Welt; 1980 Aug; 31(34):1215-7. PubMed ID: 6776381
[No Abstract] [Full Text] [Related]
7. Chemotherapy programs of the National Prostatic Cancer Project (NPCP).
Schmidt JD; Scott WW; Gibbons R; Johnson DE; Prout GR; Loening S; Soloway M; deKernion JB; Pontes JE; Slack NH; Murphy GP
Cancer; 1980 Apr; 45(7 Suppl):1937-46. PubMed ID: 6445225
[No Abstract] [Full Text] [Related]
8. Prostatic carcinoma cured with hormonal treatment. A report of two cases.
Johansson S; Ljunggren E
Scand J Urol Nephrol; 1981; 15(3):321-2. PubMed ID: 7323757
[No Abstract] [Full Text] [Related]
9. [Bilateral breast cancer as a complication of a prostatic cancer, treated with hormones].
Lindberg J; Tallgren U
Lakartidningen; 1969 Sep; 66(37):3674-8. PubMed ID: 5378939
[No Abstract] [Full Text] [Related]
10. Hormonal pattern in prostatic cancer. II. Correlation with primary response to endocrine treatment.
Adlercreutz H; Rannikko S; Kairento AL; Karonen SL
Acta Endocrinol (Copenh); 1981 Dec; 98(4):634-40. PubMed ID: 7304086
[TBL] [Abstract][Full Text] [Related]
11. [Prophylactic roentgen therapy of the breast in men treated with estrogenic hormones for prostatic cancer].
Hatteland K; Ostrem T
Tidsskr Nor Laegeforen; 1965 Sep; 85(18):1400-2. PubMed ID: 5882530
[No Abstract] [Full Text] [Related]
12. Polyestradiol phosphate (160 mg/month) or LHRH analog (buserelin depot) in the treatment of locally advanced or metastasized prostatic cancer. The Finnprostate Group.
Aro J; Ruutu M; Juusela H; Hansson E; Permi J
Ann Chir Gynaecol Suppl; 1993; 206():5-8. PubMed ID: 8291869
[TBL] [Abstract][Full Text] [Related]
13. [Long-term study of plasma testosterone levels in hormone therapy of prostatic cancer].
Hájek J; Hanselová M; Vrubel F
Vnitr Lek; 1981 Sep; 27(9):852-60. PubMed ID: 7293030
[No Abstract] [Full Text] [Related]
14. Estradiol and cognition during androgen deprivation in men with prostate carcinoma.
Wassersug RJ; Wadhwa D
Cancer; 2005 Nov; 104(9):2032-3; author reply 2033. PubMed ID: 16196043
[No Abstract] [Full Text] [Related]
15. [Serum prolactin levels during therapy of prostatic cancer with oestradiol-17 beta-undecylate and cyproterone acetate (author's transl)].
Spona J; Lunglmayr G
Wien Klin Wochenschr; 1980 Jul; 92(14):494-7. PubMed ID: 6933738
[TBL] [Abstract][Full Text] [Related]
16. The role of parenteral polyestradiol phosphate in the treatment of advanced prostatic cancer on the threshold of the new millennium.
Mikkola A; Ruutu M; Aro J; Rannikko S; Salo J
Ann Chir Gynaecol; 1999; 88(1):18-21. PubMed ID: 10230677
[TBL] [Abstract][Full Text] [Related]
17. Effect of treatment with diethylstilbestrol-polyestradiol phosphate or estramustine phosphate (estracyt) on natural killer cell activity in patients with prostatic cancer.
Kalland T; Haukaas S
Invest Urol; 1981 May; 18(8):437-9. PubMed ID: 7228576
[TBL] [Abstract][Full Text] [Related]
18. The effect of short-term estradiol therapy on clotting and inflammatory markers in older men receiving hormonal suppression therapy for prostate cancer.
Taxel P; Luthra P; Fall PM; Dauser D
Aging Male; 2008 Jun; 11(2):71-5. PubMed ID: 18570058
[TBL] [Abstract][Full Text] [Related]
19. [Clinical application of KM 2210 (estradiol-chlorambucil) in patients with advanced prostatic carcinoma].
Isurugi K
Gan No Rinsho; 1984 Jun; 30(7):810-8. PubMed ID: 6547748
[TBL] [Abstract][Full Text] [Related]
20. [Hormone therapy in carcinoma of the prostate].
Marberger H
Wien Klin Wochenschr; 1966 Jul; 78(29):512-4 passim. PubMed ID: 5992834
[No Abstract] [Full Text] [Related]
[Next] [New Search]
